Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-11 19:26:07 UTC |
---|
Update Date | 2022-03-07 02:54:09 UTC |
---|
HMDB ID | HMDB0034560 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | cis-Uvariamicin IV |
---|
Description | cis-Uvariamicin IV belongs to the class of organic compounds known as annonaceous acetogenins. These are waxy derivatives of fatty acids (usually C32 or C34), containing a terminal carboxylic acid combined with a 2-propanol unit at the C-2 position to form a methyl- substituted alpha,beta-unsaturated-gamma-lactone. One of their interesting structural features is a single, adjacent, or nonadjacent tetrahydrofuran (THF) or tetrahydropyran (THP) system with one or two flanking hydroxyl group(s) at the center of a long hydrocarbon chain. Based on a literature review a small amount of articles have been published on cis-Uvariamicin IV. |
---|
Structure | CCCCCCCCCCCCCCCCC(O)C1CCC(O1)C(O)CCCCCCCCCCC1=CC(C)OC1=O InChI=1S/C37H68O5/c1-3-4-5-6-7-8-9-10-11-12-13-17-20-23-26-33(38)35-28-29-36(42-35)34(39)27-24-21-18-15-14-16-19-22-25-32-30-31(2)41-37(32)40/h30-31,33-36,38-39H,3-29H2,1-2H3 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C37H68O5 |
---|
Average Molecular Weight | 592.9328 |
---|
Monoisotopic Molecular Weight | 592.506675286 |
---|
IUPAC Name | 3-{11-hydroxy-11-[5-(1-hydroxyheptadecyl)oxolan-2-yl]undecyl}-5-methyl-2,5-dihydrofuran-2-one |
---|
Traditional Name | 3-{11-hydroxy-11-[5-(1-hydroxyheptadecyl)oxolan-2-yl]undecyl}-5-methyl-5H-furan-2-one |
---|
CAS Registry Number | 205439-37-8 |
---|
SMILES | CCCCCCCCCCCCCCCCC(O)C1CCC(O1)C(O)CCCCCCCCCCC1=CC(C)OC1=O |
---|
InChI Identifier | InChI=1S/C37H68O5/c1-3-4-5-6-7-8-9-10-11-12-13-17-20-23-26-33(38)35-28-29-36(42-35)34(39)27-24-21-18-15-14-16-19-22-25-32-30-31(2)41-37(32)40/h30-31,33-36,38-39H,3-29H2,1-2H3 |
---|
InChI Key | RJFLREBFQAUBLY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as annonaceous acetogenins. These are waxy derivatives of fatty acids (usually C32 or C34), containing a terminal carboxylic acid combined with a 2-propanol unit at the C-2 position to form a methyl- substituted alpha,beta-unsaturated-gamma-lactone. One of their interesting structural features is a single, adjacent, or nonadjacent tetrahydrofuran (THF) or tetrahydropyran (THP) system with one or two flanking hydroxyl group(s) at the center of a long hydrocarbon chain. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Fatty alcohols |
---|
Direct Parent | Annonaceous acetogenins |
---|
Alternative Parents | |
---|
Substituents | - Annonaceae acetogenin skeleton
- Long chain fatty alcohol
- 2-furanone
- Dihydrofuran
- Tetrahydrofuran
- Enoate ester
- Alpha,beta-unsaturated carboxylic ester
- Secondary alcohol
- Lactone
- Carboxylic acid ester
- Monocarboxylic acid or derivatives
- Ether
- Dialkyl ether
- Carboxylic acid derivative
- Organoheterocyclic compound
- Oxacycle
- Organooxygen compound
- Hydrocarbon derivative
- Alcohol
- Carbonyl group
- Organic oxygen compound
- Organic oxide
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 60 - 62 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
cis-Uvariamicin IV,1TMS,isomer #1 | CCCCCCCCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(O)CCCCCCCCCCC2=CC(C)OC2=O)O1 | 4472.5 | Semi standard non polar | 33892256 | cis-Uvariamicin IV,1TMS,isomer #2 | CCCCCCCCCCCCCCCCC(O)C1CCC(C(CCCCCCCCCCC2=CC(C)OC2=O)O[Si](C)(C)C)O1 | 4472.5 | Semi standard non polar | 33892256 | cis-Uvariamicin IV,2TMS,isomer #1 | CCCCCCCCCCCCCCCCC(O[Si](C)(C)C)C1CCC(C(CCCCCCCCCCC2=CC(C)OC2=O)O[Si](C)(C)C)O1 | 4422.1 | Semi standard non polar | 33892256 | cis-Uvariamicin IV,1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCC(O[Si](C)(C)C(C)(C)C)C1CCC(C(O)CCCCCCCCCCC2=CC(C)OC2=O)O1 | 4717.9 | Semi standard non polar | 33892256 | cis-Uvariamicin IV,1TBDMS,isomer #2 | CCCCCCCCCCCCCCCCC(O)C1CCC(C(CCCCCCCCCCC2=CC(C)OC2=O)O[Si](C)(C)C(C)(C)C)O1 | 4718.2 | Semi standard non polar | 33892256 | cis-Uvariamicin IV,2TBDMS,isomer #1 | CCCCCCCCCCCCCCCCC(O[Si](C)(C)C(C)(C)C)C1CCC(C(CCCCCCCCCCC2=CC(C)OC2=O)O[Si](C)(C)C(C)(C)C)O1 | 4886.5 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - cis-Uvariamicin IV GC-MS (Non-derivatized) - 70eV, Positive | splash10-0691-2089120000-7cb8c0df9aa8e4433458 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - cis-Uvariamicin IV GC-MS (1 TMS) - 70eV, Positive | splash10-000b-5119111000-4b7a612cab66fc1b00c8 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - cis-Uvariamicin IV GC-MS ("cis-Uvariamicin IV,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - cis-Uvariamicin IV GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - cis-Uvariamicin IV GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - cis-Uvariamicin IV GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - cis-Uvariamicin IV GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - cis-Uvariamicin IV GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 10V, Positive-QTOF | splash10-002f-0021090000-5a74ae018010dabe6695 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 20V, Positive-QTOF | splash10-004r-1491140000-e4f638102f062240904b | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 40V, Positive-QTOF | splash10-0fml-2691020000-be0c4fbcfebac9d0e83a | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 10V, Negative-QTOF | splash10-0006-0010090000-6c7266807bc3fbd00d97 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 20V, Negative-QTOF | splash10-009e-1065090000-11ccfd43e47f45a83642 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 40V, Negative-QTOF | splash10-0g4j-2094010000-0eb4845aa140ca9aa52e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 10V, Negative-QTOF | splash10-0006-0000090000-c1c706cb9dbead8b3a7a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 20V, Negative-QTOF | splash10-0006-2044090000-776250f68024aa5d8e11 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 40V, Negative-QTOF | splash10-014j-9246010000-7a43547c3f7ef03822ee | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 10V, Positive-QTOF | splash10-056u-1011190000-f842c340b159e3a9eea9 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 20V, Positive-QTOF | splash10-004j-3000090000-0ef95722dbe3499da8b8 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - cis-Uvariamicin IV 40V, Positive-QTOF | splash10-0006-9001000000-c0ea59e622dcf602814f | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|
General References | - Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- (). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|